STAT Plus: Pharmalittle: WIPO holds talks to widen access to Covid-19 medical products; DEA moves to ease Covid-19 drug shortages
Good morning, everyone, and welcome to the middle of the week. Although, it might not seem that way, given the propensity for the days to blend together lately. Nonetheless, we are forging ahead with the traditional cup of stimulation — maple bourbon is our latest favorite — we invite you to join us. The neurons could use a little help, yes? Meanwhile, here are some tidbits to help you along. Keep in touch, and we hope today goes smoothly and safely.
Francis Gurry, director-general of the World Intellectual Property Organization disclosed that discussions are under way on enabling wider access to some patented drugs and medical supplies during the coronavirus pandemic, Reuters reports. During an emergency, Gurry explained that health and safety “trumps everything.” Asked about demands for access to drugs and compulsory licensing, he later noted that “this is a hot issue, and it’s a very sensitive issue as well … but extraordinary situations call for “extraordinary measures.”
Continue to STAT Plus to read the full story…
